Hodgkin Lymphoma in Adolescent Males

Epidemiologic Evidence

The National Comprehensive Cancer Network (NCCN) guidelines consistently demonstrate that Hodgkin lymphoma (HL) dominates the lymphoma landscape in adolescent males, with HL representing the most common malignancy in the 15-19 year age group, and the highest incidence occurring between ages 15-34 years 3, 4
Among adolescent males (ages 15-39 years), HL has an incidence of 3.5 per 100,000, compared to non-Hodgkin lymphoma (NHL) at 4.7 per 100,000 1, 2
In the pediatric and adolescent population under age 20, HL demonstrates a 5-year survival rate of 96%, reflecting both its prevalence and excellent treatment outcomes in this age group 3

The first and highest peak of HL incidence occurs at ages 15-34 years, directly encompassing the teenage male population in question, according to the National Cancer Institute 3, 5
The young median age at diagnosis creates unique treatment challenges, as these patients face decades of potential long-term treatment-related toxicities despite excellent cure rates exceeding 80% 3

While HL is the most common lymphoma in teenage males, it is not the most common cancer overall in this demographic, with germ cell neoplasms (testicular cancer) having the highest incidence at 11.2 per 100,000, followed by melanoma at 5.0 per 100,000, and HL ranking seventh overall 1, 2, 7